日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models

Telotristat ethyl 是一种色氨酸羟化酶抑制剂,可增强临床前胆管癌模型中标准化疗的抗肿瘤功效

Niranjan Awasthi, Lily Darman, Margaret A Schwarz, Roderich E Schwarz

Enhancing gastric cancer conventional chemotherapy effects by triple angiokinase inhibitor nintedanib in preclinical models

三联血管激酶抑制剂尼达尼布在临床前模型中增强胃癌常规化疗的效果

Niranjan Awasthi, Margaret A Schwarz, Quinn Kaurich, Changhua Zhang, Frank Hilberg, Roderich E Schwarz

Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy

通过脂质体制剂和抗血管生成联合疗法增强伊立替康的实验性胃癌活性

Niranjan Awasthi, Margaret A Schwarz, Changhua Zhang, Stephan G Klinz, Florence Meyer-Losic, Benjamin Beaufils, Arunthathi Thiagalingam, Roderich E Schwarz

Targeted dual inhibition of c-Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models

通过 foretinib 靶向双重抑制 c-Met/VEGFR2 信号传导可提高纳米颗粒紫杉醇在胃癌模型中的抗肿瘤作用

Meghan Grojean, Margaret A Schwarz, Johann R Schwarz, Sazzad Hassan, Urs von Holzen, Changhua Zhang, Roderich E Schwarz, Niranjan Awasthi

Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer

抗MMP9抗体联合白蛋白紫杉醇化疗对胰腺癌临床前模型的治疗效果

Niranjan Awasthi, Amanda J Mikels-Vigdal, Erin Stefanutti, Margaret A Schwarz, Sheena Monahan, Victoria Smith, Roderich E Schwarz

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma

拉帕替尼联合福替尼对HER2和MET共激活实验性食管腺癌的治疗作用

Md Sazzad Hassan, Fiona Williams, Niranjan Awasthi, Margaret A Schwarz, Roderich E Schwarz, Jun Li, Urs von Holzen

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma

纳米颗粒白蛋白结合紫杉醇对实验性食管腺癌的治疗效果优于克雷莫佛结合紫杉醇

Md Sazzad Hassan, Niranjan Awasthi, Jun Li, Fiona Williams, Margaret A Schwarz, Roderich E Schwarz, Urs von Holzen

Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer

在胰腺癌临床前模型中,抑制 MEK/ERK 通路可增强白蛋白紫杉醇化疗的效果

Niranjan Awasthi, Sheena Monahan, Alexis Stefaniak, Margaret A Schwarz, Roderich E Schwarz

Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity

内皮单核细胞激活多肽II介导巨噬细胞迁移,从而导致早产儿高氧诱导肺疾病的发生发展

Lee, Daniel D; Lal, Charitharth V; Persad, Elizabeth A; Lowe, Chinn-Woan; Schwarz, Anna M; Awasthi, Niranjan; Schwarz, Roderich E; Schwarz, Margaret A

Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models

在临床前胰腺癌模型中,通过抑制胰岛素样生长因子 (IGF) 信号传导来增强对白蛋白紫杉醇的反应

Niranjan Awasthi, Emily Scire, Sheena Monahan, Meghan Grojean, Eric Zhang, Margaret A Schwarz, Roderich E Schwarz